Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer
Related Posts
Yuan N, Hong GJ, Vrudhula A, Kwan AC, Duffy G, Botting P, Dhruva SS, Siegel RJ, Ouyang D. Understanding Transient Left Ventricular Ejection Fraction Reduction[...]
Tang AB, Lewsey SC, Yancy CW, Heidenreich PA, Greene SJ, Allen LA, Jessup M, Bolles M, Rutan C, Navar N, Thomas K, Fonarow GC. Get[...]
Nicoloro-SantaBarbara JM, Carroll JE, Minissian M, Kilpatrick SJ, Merz CNB, Accortt EE. Anhedonia Symptoms and High Sensitivity C-Reactive Protein (hs-CRP) Several Years Postpartum. Am J[...]